# Retracted: Studying the Role and Molecular Mechanisms of MAP4K3 in Sorafenib Resistance of Hepatocellular Carcinoma

**Authors:** BioMed Research International

PMC · DOI: 10.1155/2024/9760191 · BioMed Research International · 2024-03-20

## Full-text entities

- **Genes:** MAP4K3 (mitogen-activated protein kinase kinase kinase kinase 3) [NCBI Gene 8491] {aka GLK, MAPKKKK3, MEKKK 3, MEKKK3, RAB8IPL1}
- **Diseases:** Hepatocellular Carcinoma (MESH:D006528)
- **Chemicals:** Sorafenib (MESH:D000077157)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10977272/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC10977272/full.md

---
Source: https://tomesphere.com/paper/PMC10977272